Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal Nov. 1, 2011 By Glen Harris No AbstractRead More
Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline Nov. 1, 2011 By Glen Harris No AbstractRead More
Phenomix Seeking $86M IPO to Push Diabetes Candidate Nov. 1, 2011 By Glen Harris No AbstractRead More
Regeneron Signs Another Deal For A Potential $120M Payoff Nov. 1, 2011 By Glen Harris No AbstractRead More
